Literature DB >> 10735761

Endoscopic endonasal transsphenoidal approach to the sellar region: technical evolution of the methodology and refinement of a dedicated instrumentation.

A Alfieri1.   

Abstract

BACKGROUND: Endoscopic treatment of hydrocephalus has in time acquired a primary position in Neurosurgery. Today endoscopy can be employed in the vast majority of neurosurgical procedures in the realization of the so-called endoscope-assisted microneurosurgery. On the basis of the encouraging results obtained by Jho and Carrau, the authors report the pros and cons of the new endoscopic endonasal technique.
METHODS: An endoscopic endonasal transsphenoidal approach to the sella was performed in 50 patients: 33 females and 17 males, of age included between 16 and 76 years; 45 were affected by pituitary adenomas (9 micro and 36 macro; 10 were recurrences), 3 by craniopharyngiomas, 2 by clival chordomas. The new instrumentation was realized through straight devices with a handle shifted 10-30 degrees horizontally. The possible danger to the nasal structures is reduced not only by the elimination of the bayonet-like shape but also by hiding the cutting extremity in the handle.
RESULTS: The advantages of this technique have been represented by an easier access to the lesion, especially in recurrent tumors, a more complete excision of voluminous neoplasms, a decrease of ENT post-surgical complications and a reduction of hospitalization times and costs. The main limits have been the reduction of field depth and the lack of adequate instrumentation.
CONCLUSIONS: In this peculiar surgery the absence of proper instruments has to be overcome because: a) there is less room to work, b) a conflict between the hands of the surgeon and the endoscope may occur, c) the blind introduction of the instruments in the nostril may cause damage to the nasal structures. The secret for the success of the endoscopic endonasal transsphenoidal technique is to create the optimal conditions, in order to avoid improper manoeuvres that may cause potential dangers.

Entities:  

Mesh:

Year:  1999        PMID: 10735761

Source DB:  PubMed          Journal:  J Neurosurg Sci        ISSN: 0390-5616            Impact factor:   2.279


  7 in total

Review 1.  Microsurgical resection of skull base meningioma-expanding the operative corridor.

Authors:  Amol Raheja; William T Couldwell
Journal:  J Neurooncol       Date:  2016-07-20       Impact factor: 4.130

2.  Endoscopic endonasal partial middle turbinectomy approach: adaptability of the procedure in a cadaveric study and in surgery for different sphenoid sinus and skull base lesions.

Authors:  Omar A El-Banhawy; Abd El-Hafiz Shehab El-Dien; Ahmed Said Zolfakar; Ahmed N Halaka; Heshmat Ayad
Journal:  Skull Base       Date:  2006-02

Review 3.  Transsphenoidal and transcranial surgery for pituitary adenomas.

Authors:  William T Couldwell
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

4.  Microscopic surgery for pituitary adenomas to preserve the pituitary gland and stalk.

Authors:  Hao-Yu Li; Cheng-Yuan Feng; Chi Zhang; Jun Su; Jian Yuan; Yuanyang Xie; Yiwei Liao; Xianrui Yuan; Qing Liu
Journal:  Exp Ther Med       Date:  2017-01-19       Impact factor: 2.447

5.  Utility of Nasal Access Guides in Endoscopic Endonasal Skull Base Surgery: Assessment of Use during Cadaveric Dissection and Workflow Analysis in Surgery.

Authors:  Nathalia Velasquez; Omar H Ahmed; Philippe Lavigne; Ezequiel Goldschmidt; Paul A Gardner; Carl H Snyderman; Eric W Wang
Journal:  J Neurol Surg B Skull Base       Date:  2020-09-10

Review 6.  The implications of microsurgical anatomy for surgical approaches to the sellar region.

Authors:  Gustavo Rassier Isolan; Paulo Henrique Pires de Aguiar; Edward R Laws; Atahualpa Cauê Paim Strapasson; Otávio Piltcher
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

7.  Safe Corridor to Access Clivus for Endoscopic Trans-Sphenoidal Surgery: A Radiological and Anatomical Study.

Authors:  Ye Cheng; Siwen Zhang; Yong Chen; Gang Zhao
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.